Vector Sciences, Inc. Information

BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics. Renowned founder, Dan Barouch, MD, PhD, William Bosworth Castle Professor of Medicine at Harvard and the Director of the Center for Virology and Vaccine Research at BIDMC has been extremely successful in unraveling the immunology of infectious diseases and development of effective vaccines, including the COVID-19 vaccine marketed by J&J. Dan Barouch has led numerous novel vaccine candidates through discovery, into the clinic through to licensure. The president, Peter Abbink, PhD, developed the RheoVax platform, and developed the Ad26 vector used in the licensed Ebola and COVID-19 vaccines of J&J. In addition, Peter has led divisions at two CDMO companies through growth and acquisition. The company has a deeply experienced team of biotech, pharma, and entrepreneurial advisors.